Search Results - "VAN AST, J. F"

The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening by Christiaans, Imke, Birnie, Erwin, van Langen, Irene M., van Spaendonck-Zwarts, Karin Y., van Tintelen, J. Peter, van den Berg, Maarten P., Atsma, Douwe E., Helderman-van den Enden, Apollonia T.J.M., Pinto, Yigal M., Hermans-van Ast, J.F., Bonsel, Gouke J., Wilde, Arthur A.M.

“…Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM) and of risk factors for sudden cardiac death (SCD) at the first…”
Get full text

Diagnostic reference frames for seizures : A validation study by VAN AST, J. F, RENIER, W. O, TALMON, J. L, ROOS, J. M. A, HASMAN, A

“…We developed structured descriptions of signs and symptoms for specific seizure types (called Diagnostic Reference Frames-DRFs-by us) that can serve as a frame…”
Get full text

An approach to knowledge base construction based on expert opinions by van Ast, J F, Talmon, J L, Renier, W O, Hasman, A

“…To describe, validate and demonstrate an approach for knowledge base construction based on expert opinions. A knowledge base containing the frequency of…”
Get more information

Development of diagnostic reference frames for seizures. Part 2: are seizure descriptions discriminative? by van Ast, J.F., Talmon, J.L., Renier, W.O., Meinardi, H., Ahles, P.P.M., Hasman, A.

“…Objective: To determine whether the seizure descriptions given by a group of neurologists/epileptologists are discriminative. Method: We constructed templates…”
Get full text

Development of diagnostic reference frames for seizures. Part 1: inter-participant agreement in the selection of symptoms by van Ast, J.F., Talmon, J.L., Renier, W.O., Ahles, P.P.M., Hasman, A.

“…Objective: Our aim is to develop reliable descriptions of various seizure types, which will be used as a basis for decision support. We use expert opinions in…”
Get full text

The Netherlands Heart Tissue Bank: Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue Repository by Henkens, M. T. H. M., van Ast, J. F., te Riele, A. S. J. M., Houweling, A. C., Amin, A. S., Nijveldt, R., Antoni, M. L., Li, X., Wehrens, S. M. T., von der Thüsen, J. H., Damman, K., ter Horst, E. N., Manintveld, O. C., Abma-Schouten, R. Y., Niessen, H. W. M., Silljé, H. H. W., Jukema, J. W., Doevendans, P. A.

“…Aim Cardiac diseases remain a leading cause of cardiovascular disease (CVD) related hospitalisation and mortality. That is why research to improve our…”
Get full text

Sex differences in cardiovascular complications and mortality in hospital patients with covid-19: registry based observational study by Hockham, Carinna, Linschoten, Marijke, Asselbergs, Folkert W, Ghossein, Chahinda, Woodward, Mark, Peters, Sanne A E, Al-Ali, AK, Al-Muhanna, FA, Al-Windy, NYY, Almubarak, YA, Alnafie, AN, Alshahrani, M, Alshehri, AM, Anthonio, RL, Asselbergs, FW, Aujayeb, A, ten Berg, JM, van Boxem, AJM, Captur, G, Caputo, M, Charlotte, N, De Sutter, J, Delsing, CE, Dorman, HGR, Drost, JT, Emans, ME, Ferreira, JB, Gabriel, L, van Gilst, WH, Groenemeijer, BE, Haerkens-Arends, HE, van der Harst, P, Hedayat, B, van der Heijden, DJ, Hellou, E, Hermanides, RS, Hermans-van Ast, JF, van Hessen, MWJ, Heymans, SRB, van der Horst, ICC, van Ierssel, SH, Kearney, MT, van Kesteren, HAM, BLJH, Kietselaer, Koning, AMH, Kopylov, PY, Kuijper, AFM, Kwakkel-vanErp, JM, Linden MMJM, van der, Linssen, GCM, Ruiz R, Macias, Magdelijns, FJH, FMAC, Martens, van der Meer, P, Meijs, MFL, Messiaen, P, Monraats, PS, Montagna, L, Moriarty, A, Mosterd, A, Nierop, PR, van Ofwegen-Hanekamp, CEE, Pinto, YM, Poorhosseini, H, Prasad, S, Reidinga, AC, Ribeiro, MIA, Salah, R, Saneei, E, Saxena, M, Schaap, J, DAAM, Schellings, Schut, A, Shafiee, A, Shore, AC, Siebelink, HJ, van Smeden, M, Pisters, R, Tessitore, E, Tieleman, RG, Timmermans, P, Tio, RA, den Uil, CA, Van Craenenbroeck, EM, HPAA, van Veen, Veneman, T, Verschure, DO, de Vries, JK, van de Wal, RMA, van de Watering, DJ, Westendorp, ICD, Westendorp, PHM, Weytjens, C, Wierda, E, Williams, B, Woudstra, P, Wu, KW, Zaal, R, Zaman, AG, van derZee, PM

“…ObjectiveTo assess whether the risk of cardiovascular complications of covid-19 differ between the sexes and to determine whether any sex differences in risk…”
Get full text

Inter-participant agreement in the selection of symptoms for the description of seizures by van Ast, J F, Talmon, J L, Ahles, P P M, Hasman, A

“…To evaluate the inter-participant agreement in the selection of symptoms for the description of seizure types. We evaluated the inter-participant agreement for…”
Get more information

Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers by van Rijsingen, I. A. W., Bekkers, S. C. A. M., Schalla, S., Hermans-van Ast, J. F., Snoep, G., Alzand, B. S. N., Arens, Y. H. J. M., van den Wijngaard, A., Crijns, H. J. G. M., Pinto, Y. M.

“…Aims Hypertrophic cardiomyopathy (HCM) is a frequent cause of sudden cardiac death (SCD) due to exercise-related ventricular arrhythmias (ERVA); however the…”
Get full text

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study by Henkens, M T H M, Raafs, A G, Verdonschot, J A J, Linschoten, M, van Smeden, M, Wang, P, van der Hooft, B H M, Tieleman, R, Janssen, M L F, Ter Bekke, R M A, Hazebroek, M R, van der Horst, I C C, Asselbergs, F W, Magdelijns, F J H, Heymans, S R B

“…Age and comorbidities increase COVID-19 related in-hospital mortality risk, but the extent by which comorbidities mediate the impact of age remains unknown. In…”
Get full text

Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity? by van Rijsingen, I. A. W., Ast, J. F. Hermans-van, Arens, Y. H. J. M., Schalla, S. M., de Die-Smulders, C. E. M, van den Wijngaard, A., Pinto, Y. M.

“…Background. With the improvement in genetic testing over time, double-heterozygous mutations are more often found by coincidence in families with hypertrophic…”
Get full text

How many neurologists/epileptologists are needed to provide reliable descriptions of seizure types? by van Ast, J F, Talmon, J L, Renier, W O, Hasman, A

“…We are developing seizure descriptions as a basis for decision support. Based on an existing dataset we used the Spearman-Brown prophecy formula to estimate…”
Get more information

The Netherlands Heart Tissue Bank by Henkens, M. T. H. M, van Ast, J. F, te Riele, A. S. J. M, Houweling, A. C, Amin, A. S, Nijveldt, R, Antoni, M. L, Li, X, Wehrens, S. M. T, von der Thüsen, J. H, Damman, K, ter Horst, E. N, Manintveld, O. C, Abma-Schouten, R. Y, Niessen, H. W. M, Silljé, H. H. W, Jukema, J. W, Doevendans, P. A

“…AimCardiac diseases remain a leading cause of cardiovascular disease (CVD) related hospitalisation and mortality. That is why research to improve our…”
Get full text